Point of Care Diagnostics Testing Market Analysis

Point of care diagnostics/testing Market Overview

Point Of Care Diagnostics Testing Market Size was valued at USD 52.70 Billion in 2023. The Global Point Of Care Diagnostics Testing industry is projected to grow from USD 57.71 Billion in 2024 to USD 119.36 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.77% during the forecast period (2024 - 2032). 

Point of care diagnostics/testing is a health analysis that is carried out near the patient and does not include any laboratory setting. Point of Care (POC) testing is also called near-patient testing, bedside testing, mobile testing, remote testing, and rapid diagnosis. The procedure is used to diagnose infectious diseases in sites with limited healthcare infrastructure. POC testing offers instant diagnostic results minimizing the number of patient visits, increasing diagnosis efficiency, and enabling timely treatment. 

In addition, it streamlines the testing process for the healthcare personnel and provides effective results. The POC testing devices are utilized to carry out diagnostic tests such as blood glucose level tests, levels of blood gases, analysis of electrolytes and enzymes, and tests for signs of infection. These devices run on different principles, including Lateral-Flow Immunochromatographic Assay (LFIA), molecular, and biochemical. Furthermore, portability, convenience, connectivity, speed, and result assurance areaugmenting the demand for POC testing products.

With an increasing number of chronic disorderssuch as diabetes across the globe and a limited number of healthcare facilities in the developing economies, the introduction of portable POC devices supporting government policies is augmenting the POC diagnostics/testing market. Moreover, the market players are offering digital and wireless POC solutions to increase the efficiency and accuracy of the diagnosis. The new era POCs are connected with smartphones and display the analysis and test results on the connected device. Additionally, this advancement has allowed the medical practitioners and the patients to manage the diagnosed data and maintain the records in an electrical format. These factors are driving the demand for POC diagnostic/testing products throughout the globe.

COVID-19 Analysis

The pandemic outbreak ceased the operations of all the sectors throughout the globe. The healthcare industry was hit hard during the initial phase of the lockdown. Medical stocks were piled up in large numbers, and the number of the produced goods rose as the supply chain within and across borders was highly affected due to the implementation of the safety guidelines. However, after the decline in the number of affected cases, the regulatory authorities allowed the limited mobility and manufacturing of the essential products. The relaxation in the guidelines accelerated the demand for healthcare products supporting the point of care diagnostics/testing market.

During the pandemic, the market players invested huge amounts in the development of rapid tests to diagnose COVID-19. According to WHO, in September 2020, the industry players partnered to develop 120 million economic antigen-based rapid diagnostic POC tests for developing countries. Bill & Melinda Gates Foundation (US), SD BioSensor Inc. (South Korea), and Abbott Laboratories (US) signed an agreement to offer the POC test products for a maximum price of USD 5. The Global Fund allotted USD 50 million to enable low- and middle-income countries (LMICs)to buy the diagnostic test product. Moreover, in September 2020 FDA authorized the POC antibody test for COVID-19 that will allow people to understand their health status and let them know whether the virus has infected them or not. Furthermore, the regulatory authorities updated their guidelines related to the SARS-CoV-2 pointof care and rapid testing. These supportive factors propelled the market growth and are expected to augment in the forecast period.

Point of care diagnostics/testing Market Trends

• Increasing demand for COVID-19 POC test kits

Increasing cases of coronavirus across the globe have augmented the demand for self-diagnosing kits and devices. Restricted mobility has accelerated the demand for POCs for diagnosing different variants of coronavirus. In addition, international healthcare authorities such as WHO)have shared guidelines related to the COVID-POCs to increase the self-diagnosis of the disease, further preventing the spread of the fatal virus. Moreover, a few market players are launching new products to gain a competitive edge over their competitors. For instance, in March 2020,Abbott Laboratories (US) launched a molecular pointofcare test to detect coronavirus within 5 minutes. The company delivered 50,000 tests every day. Moreover, the increasing population diagnosed with chronic diseases is driving the POC diagnostic/testing market.

• Risingnumber of chronic disease cases across the globe


• Growing demand for AI integrated POCs for real-time diagnostics

• Stringent regulatory policies

The healthcare regulation varies regionally, which is one of the major challenges faced by device manufacturers to deploy their devices in compliance with the regional authorities. The multi-layered regulations established by the international governing authorities such as FDA and CLIA are restraining the market growth of the POC manufacturers and creating a regulatory barrier in the promotion and sales of their products. In addition, the healthcare device manufacturers have to submit the performance data of their products stating the pros and cons of the product on the tested individuals. These authorities verify the accessibility and challenges of the POCrelated to the product administration. These actors are hindering the market growth of the POC diagnostics/testing market across the globe.

• Technology Analysis

Point of care diagnostics/testing Market Segment Insights

Point of care diagnostics/testing Product Insights

• Glucose Monitoring: It is a type of device in which glucose concentrationin the blood is measuredusing a lancet, meter, or any other device.


• Cardiometabolic Monitoring: It is a type of monitoring device in which risk related to cardiovascular functions such as blood pressure, blood gas,blood fat, LDL (low-density lipoprotein) levels, etc., is monitored.


• Infectious Disease Testing: It is a type of device which detects disorders caused by organisms such as viruses, bacteria, and fungi.


• Coagulation Monitoring: It is a type of device in which blood clotting ability is tested. It will provide significant analysis to the doctors about the proper deployment of the clotting factor in the bleeding area.


• Pregnancy & Fertility Testing: It is a type of device that tests the ability to conceive naturally and the presence of any kind of sexually transmitted diseases in both men and women.


• Hematology Testing:These devices carry out blood tests to evaluate complete blood count, protein levels, infection, inflammation, blood-clotting disorders, anemia, and leukemia.


• Cancer/Tumor Marker Testing:It is a device in which tumor markers in the blood, tissue, urine, and other body fluids are monitored. The device tracks the protein and other substances that are formed in response to the tumor cells.


• Urinalysis Testing: This device diagnoses urinary tract infections, detects kidney disorders, diabetes levels, liver problems, and other metabolic functions.


• Cholesterol: It is a type of device that measures high-density and low-density proteins and certain fats in the blood.


• Drugs-of-Abuse Testing: It is a type of device that measures illegal substances for non-medical reasons in urine, saliva, blood, hair, and sweat.

Point of care diagnostics/testing End User Insights

• Hospitals & Clinics Hospitals & Clinics are the organizations that offer medical and surgical treatment to the wounded.


• Diagnostic Centers It is a place where diagnostic services are offered to the general public and medical practitioners.


• Homecare/Self Testing It is healthcare support offered by the professional caregiver for health services to patients in their homes.

Point of care diagnostics/testing Mode of Purchase Insights

• OTC Testing Products It is a type of test that does not require a prescription and isindependent of healthcare settings.


• Prescription-based testing products It is a type of test that is carried out based on the prescription by the doctor.

Point of care diagnostics/testing Platform Insights

• Immunoassays It is a platformused to measure particular proteins and supplementary substances through their antigen and antibody properties.


• Molecular Diagnostics It is a platform used to identify disease using molecules such as DNA, RNA, tissue, fluid, and proteins.


• Dipsticks It is a chemical integrated sensitive strip of paper used to detect glucose, protein, and other components in urine.